- Home
- / Cytek Biosciences
Cytek Biosciences
Stock Price
$4.8
2024-10-29
Market Capitalization
$632.5 M
2024-10-29
Revenue
$201.5 M
FY, 2025
Cytek Biosciences Summary
Company Summary
- Overview
- Cytek Biosciences is a manufacturer and supplier of flow cytometry products and services. It offers an analytical tool used for identifying and quantifying cellular characteristics on a cell-by-cell basis.
- Type
- Public
- Status
- Active
- Founded
- 1992
- HQ
- Fremont, CA, US | view all locations
- Website
- https://cytekbio.com/
- Cybersecurity rating
- ESG rating
Table of Contents
Key People
Ming Yan, CTO
Valerie Barnett, General Counsel and Corporate Secretary
Patrik Jeanmonod, CFO
LocationsView all
6 locations detected
Fremont, CA HQ
United States
46107 Landing Pkwy
Bethesda, MD
United States
4520 East West Highway, Suite 615
Shanghai, Shanghai Shi
China
560 Shengxia Road, Suite 603
Tokyo, Tōkyō-to
Japan
2-9-1 Ikenohata, Taito-ku
Amsterdam, NH
Netherlands
Amstelveenseweg 638
Amsterdam, NH
Netherlands
Paasheuvelweg 25, tower c5
Cytek Biosciences Financials
Summary Financials
- Revenue (Q1, 2026)
- $44.1M
- Gross profit (Q1, 2026)
- $21.3M
- Net income (Q1, 2026)
- ($18.9M)
- Cash (Q1, 2026)
- $65.7M
- EBIT (Q1, 2026)
- ($18.5M)
- Enterprise value
- $580.7M